You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 8, AUGUST 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (46)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Presenting Features and Outcomes in Patients Undergoing Temporal Artery Biopsy

A Review of 98 Patients

Walter L. Chmelewski, MD; Kevin M. McKnight, MD; Carlos A. Agudelo, MD; Christopher M. Wise, MD

Arch Intern Med. 1992;152(8):1690-1695.


Abstract

Background.—
Although temporal arteritis is a wellrecognized syndrome, controversy still exists regarding the optimal approach to diagnosis and treatment of this condition. We undertook this review to further define the spectrum of presenting features and outcomes of patients undergoing temporal artery biopsy.

Methods.—
We reviewed the records of all patients undergoing temporal artery biopsy over a 5-year period. Presenting features were compared in biopsy-positive and biopsy-negative patients. In patients with positive biopsy specimens, treatment regimens, disease, treatment-related morbidity, and outcomes were recorded. Alternative diagnoses and therapy were reviewed in biopsy-negative patients.

Results.—
Of 98 patients, 30 had positive and 68 had negative biopsy specimens. Biopsy-positive patients had an increased incidence of headache (93% vs 62%), jaw claudication (50% vs 18%), and prior polymyalgia rheumatica (23% vs 3%), but the sensitivity and specificity of these indicators were relatively low. Other clinical and laboratory parameters, including prior steroids and erythrocyte sedimentation rate, were similar between the two groups. In 30 patients with positive biopsy specimens, response to initial high-dose steroid was excellent. Serious manifestations after initial treatment were not seen, but mild flares were common after 1 year of therapy. Steroid-related morbidity was common, and steroids were seldom discontinued (0/22 patients at 1 year, 6/19 patients at 2 years, 5/11 patients at 3 years). In 68 patients with negative biopsy specimens, alternative diagnoses included neurologic diseases (15 patients), "pure" polymyalgia rheumatica (14 patients), and other inflammatory rheumatologic diseases (10 patients). Fourteen patients with negative biopsy specimens were treated for temporal arteritis, and were similar to biopsypositive patients.

Conclusions.—
Temporal arteritis remains a challenging condition to diagnose and to treat. Presenting features are seldom helpful in predicting biopsy results. Initial treatment is effective but frequently toxic. Although late diseaserelated complications are rare, most patients continue to take long-term low-dose steroid therapy.

(Arch Intern Med. 1992;152:1690-1695)



Author Affiliations

From the Section on Rheumatology, Department of Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC. Drs Chmelewski, McKnight, and Agudelo are now with the North Carolina Arthritis and Allergy Care Center, Raleigh, the Kinston (NC) Internal Medicine, and the Atlanta (Ga) Veterans Administration Hospital and Emory University School of Medicine, respectively.


Footnotes

Accepted for publication February 25, 1992.

Presented at the 55th annual Scientific Session of the American College of Rheumatology, Boston, Mass, November 18, 1991.

Reprint requests to the Section on Rheumatology, Bowman Gray School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157 (Dr Wise).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk factors for early visual deterioration in temporal arteritis
Loddenkemper et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:1255-1259.
ABSTRACT | FULL TEXT  

Epidemiology of giant-cell arteritis in an Arab population: a 22-year study
Chaudhry et al.
Br J Ophthalmol 2007;91:715-718.
ABSTRACT | FULL TEXT  

Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases
Font and Prabhakaran
Br J Ophthalmol 2007;91:204-209.
ABSTRACT | FULL TEXT  

Initiation of Glucocorticoid Therapy: Before or After Temporal Artery Biopsy?
Younge et al.
Mayo Clin Proc. 2004;79:483-491.
ABSTRACT  

Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis
Ray-Chaudhuri et al.
Br J Ophthalmol 2002;86:530-532.
ABSTRACT | FULL TEXT  

Does This Patient Have Temporal Arteritis?
Smetana and Shmerling
JAMA 2002;287:92-101.
ABSTRACT | FULL TEXT  

Temporal artery biopsy in the management of giant cell arteritis with neuro-ophthalmic complications
Riordan-Eva et al.
Br J Ophthalmol 2001;85:1248-1251.
FULL TEXT  

Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease
Duhaut et al.
Ann Rheum Dis 1999;58:335-341.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.